Skip to main content
Log in

Role of β3-Adrenoceptor Activation in Changes of Pulmonary Microhemodynamics after Experimental Pulmonary Thromboembolism

  • Published:
Bulletin of Experimental Biology and Medicine Aims and scope

Changes in pulmonary microhemodynamics during modelling of pulmonary thromboembolism against the background of nebivolol and mirabegron pretreatment were studied in isolated perfused rabbit lungs. In both cases, the pulmonary artery pressure and precapillary and pulmonary vascular resistance increased to a greater extent than in control animals, but the increase in capillary hydrostatic pressure was less pronounced. The postcapillary resistance did not change in pulmonary embolism against the background of nebivolol administration and increased in case of mirabegron pretreatment; capillary filtration coefficient after nebivolol pretreatment increased less markedly than after mirabegron administration. The increase in capillary filtration coefficient after activation of β3-adrenoceptors with the specified drugs depended on the ratio of constriction of pulmonary veins, capillary hydrostatic pressure, and endothelial permeability.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Evlakhov VI, Poyasov IZ. Adrenergic mechanisms of regulation of pulmonary microvessels tonicity and endothelial permeability. Angiologiya Sosud. Khirurgiya. 2019;25(3):11-16. Russian.

    CAS  Google Scholar 

  2. Evlakhov VI, Poyassov IZ. Pulmonary macro- and microhemodynamics after the blocadeof alfa- and beta-adrenoceptors in the experimental pulmonary thromboembolism model. Ross. Fiziol. Zh. 2019;105(7):902-912. Russian.

    Google Scholar 

  3. Mashkovskii MD. Drugs. Moscow, 2012. Russian.

    Google Scholar 

  4. Bäck M, Walch L, Norel X, Gascard J. P, Mazmanian G, Brink C. Modulation of vascular tone and reactivity by nitric oxide in porcine pulmonary arteries and veins. Acta Physiol. Scand. 2002;174(1):9-15.

    PubMed  Google Scholar 

  5. Dal Negro R. Pulmonary effects of nebivolol. Ther. Adv. Cardiovasc. Dis. 2009;3(4):329-334. doi: https://doi.org/10.1177/1753944709339968

    Article  PubMed  Google Scholar 

  6. Durán WN, Beuve AV, Sánchez FA. Nitric oxide, S-nitrosation, and endothelial permeability. IUBMB Life. 2013;65(10):819-826. doi: https://doi.org/10.1002/iub.1204

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Figueroa XF, Poblete I, Fernández R, Pedemonte C, Cortés V, Huidobro-Toro JP. NO production and eNOS phosphorylation induced by epinephrine through the activation of beta-adrenoceptors. Am. J. Physiol. Heart Circ. Physiol. 2009;297(1):H134- H143. doi: https://doi.org/10.1152/ajpheart.00023.2009

    Article  CAS  PubMed  Google Scholar 

  8. García-Álvarez A, Pereda D, García-Lunar I, Sanz-Rosa D, Fernández-Jiménez R, García-Prieto J, Nuño-Ayala M, Sierra F, Santiago E, Sandoval E, Campelos P, Agüero J, Pizarro G, Peinado VI, Fernández-Friera L, García-Ruiz JM, Barberá JA, Castellá M, Sabaté M, Fuster V, Ibañez B. Beta-3 adrenergic agonists reduce pulmonary vascular resistance and improve right ventricular performance in a porcine model of chronic pulmonary hypertension. Basic Res. Cardiol. 2016;111(4):49. doi: https://doi.org/10.1007/s00395-016-0567-0

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Gauthier C, Sèze-Goismier C, Rozec B. Beta 3-adrenoceptors in the cardiovascular system. Clin. Hemorheol. Microcirc. 2007;37(1-2):193-204.

    CAS  PubMed  Google Scholar 

  10. Krauwinkel W, van Dijk J, Schaddelee M, Eltink C, Meijer J, Strabach G, van Marle S, Kerbusch V, van Gelderen M. Pharmacokinetic properties of mirabegron, a β3-adrenoceptor agonist: results from two phase I, randomized, multiple-dose studies in healthy young and elderly men and women. Clin. Ther. 2012;34(10):2144-2160. doi: https://doi.org/10.1016/j.clinthera.2012.09.010

    Article  CAS  PubMed  Google Scholar 

  11. Pankey EA, Edward JA, Swan KW, Bourgeois CR, Bartow MJ, Yoo D, Peak TA, Song BM, Chan RA, Murthy SN, Prieto MC, Giles TD, Kadowitz PJ. Nebivolol has a beneficial effect in monocrotaline-induced pulmonary hypertension. Can. J. Physiol. Pharmacol. 2016;94(7):758-768. doi: https://doi.org/10.1139/cjpp-2015-0431

    Article  CAS  PubMed  Google Scholar 

  12. Perros F, Ranchoux B, Izikki M, Bentebbal S, Happé C, Antigny F, Jourdon P, Dorfmüller P, Lecerf F, Fadel E, Simonneau G, Humbert M, Bogaard HJ, Eddahibi S. Nebivolol for improving endothelial dysfunction, pulmonary vascular remodeling, and right heart function in pulmonary hypertension. J. Am. Coll. Cardiol. 2015;65(7):668-680. doi: https://doi.org/10.1016/j.jacc.2014.11.050

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to V. I. Evlakhov.

Additional information

Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 169, No. 6, pp. 691-694, June, 2020

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Evlakhov, V.I., Berezina, T.P. & Poyassov, I.Z. Role of β3-Adrenoceptor Activation in Changes of Pulmonary Microhemodynamics after Experimental Pulmonary Thromboembolism. Bull Exp Biol Med 169, 751–754 (2020). https://doi.org/10.1007/s10517-020-04971-x

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10517-020-04971-x

Key Words

Navigation